AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33794781 — intervention group
Group type: EXPERIMENTAL
Intervention: 5A online tutorial for general practitioners
Number of subjects: 160
Study 33794781 — intervention group
Group type: COMPARATOR
Intervention: Control (usual treatment)
Number of subjects: 160
Study 32114331 — intervention group
Group type: EXPERIMENTAL
Intervention: smartteen (cCBT)
Number of subjects: 21
Study 32114331 — intervention group
Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 21
Study 33722758 — intervention group
Group type: EXPERIMENTAL
Intervention: Greedy Rabbit exergame (experimental group, n = 41)
Number of subjects: 60
Study 33722758 — intervention group
Group type: COMPARATOR
Intervention: Placebo version of Greedy Rabbit (control group, n = 19)
Number of subjects: 60
Study 32900508 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 100 μg
Number of subjects: 60
Study 32900508 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 mg isobaric bupivacaine 0.5% with 0.5 ml normal saline 0.9%)
Number of subjects: 60
Study 32900508 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 36694242 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational material and SMS reminders
Number of subjects: 300
Study 36694242 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (weekly pick-up with monthly check-ups)
Number of subjects: 300
Study 33638741 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw augmentation with bone cement
Number of subjects: 8
Study 33638741 — intervention group
Group type: COMPARATOR
Intervention: No screw augmentation
Number of subjects: 8
Study 33638741 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented screws
Number of subjects: 8
Study 33638741 — intervention group
Group type: COMPARATOR
Intervention: Nonaugmented screws
Number of subjects: 8
Study 32546646 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant 250 mg
Number of subjects: 383
Study 32546646 — intervention group
Group type: COMPARATOR
Intervention: Exemestane
Number of subjects: 383
Study 35664249 — intervention group
Group type: EXPERIMENTAL
Intervention: Ideal Protein (IP) Phase I diet
Number of subjects: 192
Study 35664249 — intervention group
Group type: COMPARATOR
Intervention: Low-calorie/low-fat (LCLF) diet
Number of subjects: 192
Study 34495285 — intervention group
Group type: EXPERIMENTAL
Intervention: Online 1-day cognitive behavioral therapy (CBT)-based workshop plus usual care (n = 202)
Number of subjects: 403
Study 34495285 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (wait-listed control group, n = 201)
Number of subjects: 403
Study 34325050 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive screening for gout
Number of subjects: 4916
Study 34325050 — intervention group
Group type: EXPERIMENTAL
Intervention: De novo diagnoses of gout
Number of subjects: 4916
Study 34325050 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted prevalence of gout
Number of subjects: 4916
Study 33508495 — intervention group
Group type: EXPERIMENTAL
Intervention: COC users (Microgynon®) during day 15-16 of pill consumption (PC2)
Number of subjects: 28
Study 33508495 — intervention group
Group type: EXPERIMENTAL
Intervention: COC users (Microgynon®) during day 2-3 of pill consumption (PC1)
Number of subjects: 28
Study 33508495 — intervention group
Group type: COMPARATOR
Intervention: Eumenorrheic women
Number of subjects: 28
Study 34766424 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744
Study 34766424 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study 33126375 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior minimally invasive oblique retroperitoneal approach (ORA)
Number of subjects: 50
Study 33126375 — intervention group
Group type: COMPARATOR
Intervention: Posterior transpedicular approach (PTA)
Number of subjects: 50
Study 33126375 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative pain score
Number of subjects: 50
Study 33126375 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical recovery
Number of subjects: 50
Study 33536154 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led transitions of care program
Number of subjects: 88
Study 33536154 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 88
Study 32246696 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D miniplates (2.0‐mm titanium plates)
Number of subjects: 120
Study 32246696 — intervention group
Group type: COMPARATOR
Intervention: 2D miniplates (2.0‐mm titanium miniplate)
Number of subjects: 120
Study 32246696 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D miniplates
Number of subjects: 120
Study 32246696 — intervention group
Group type: COMPARATOR
Intervention: 2D miniplates
Number of subjects: 120
Study 35728068 — intervention group
Group type: EXPERIMENTAL
Intervention: mentoring + mindfulness
Number of subjects: 49
Study 35728068 — intervention group
Group type: COMPARATOR
Intervention: mentoring-as-usual
Number of subjects: 49
Study 32407717 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group (HRG)
Number of subjects: 87
Study 32407717 — intervention group
Group type: EXPERIMENTAL
Intervention: Preeclampsia group (PEC)
Number of subjects: 87
Study 32407717 — intervention group
Group type: EXPERIMENTAL
Intervention: Research model parameters
Number of subjects: 87
Study 36397060 — intervention group
Group type: EXPERIMENTAL
Intervention: Dosiomics model
Number of subjects: 140
Study 36397060 — intervention group
Group type: EXPERIMENTAL
Intervention: DLR model
Number of subjects: 140
Study 36397060 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid model
Number of subjects: 140
Study 32043148 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised rehabilitation intervention (physical therapy and occupational therapy-based interventions)
Number of subjects: 64
Study 32043148 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised rehabilitation intervention
Number of subjects: 64
Study 32043148 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation care
Number of subjects: 64
Study 33421267 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled and intravenous sodium nitrite
Number of subjects: 51
Study 32410849 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone Metformin complex (PM)
Number of subjects: 75
Study 32965471 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) training
Number of subjects: 0
Study 32965471 — intervention group
Group type: COMPARATOR
Intervention: Control group (untrained)
Number of subjects: 0
Study 32132264 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal stimulation to the right temporoparietal junction (rTPJ)
Number of subjects: 88
Study 32132264 — intervention group
Group type: COMPARATOR
Intervention: Stimulation to the dorsomedial PFC
Number of subjects: 88
Study 34697657 — intervention group
Group type: EXPERIMENTAL
Intervention: nano-silver (nano-Ag)
Number of subjects: 69
Study 34697657 — intervention group
Group type: EXPERIMENTAL
Intervention: nano-calcium hydroxide (nano-CH)
Number of subjects: 69
Study 34697657 — intervention group
Group type: COMPARATOR
Intervention: calcium hydroxide (CH)
Number of subjects: 69
Study 34697657 — intervention group
Group type: COMPARATOR
Intervention: Cleaning and shaping (S1-S2)
Number of subjects: 69
Study 34697657 — intervention group
Group type: COMPARATOR
Intervention: All groups (nano-Ag, nano-CH, CH)
Number of subjects: 69
Study 32831070 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-risk groups (Group 0: 72.72%, Group 1: 5.9%, Group 2: 17.73%, Group 3: 3.63%)
Number of subjects: 230
Study 32831070 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinopathy
Number of subjects: 230
Study 32831070 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperkeratosis
Number of subjects: 230
Study 32831070 — intervention group
Group type: EXPERIMENTAL
Intervention: School level
Number of subjects: 230
Study 36316421 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (atDCS) applied to the left Dorsolateral Prefrontal Cortex (DLPFC)
Number of subjects: 31
Study 36316421 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 31
Study 33547702 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Patient‐Reported Outcome Measures (DiaPROM) pilot trial intervention
Number of subjects: 19
Study 33547702 — intervention group
Group type: COMPARATOR
Intervention: Previous follow-up
Number of subjects: 19
Study 33547702 — intervention group
Group type: EXPERIMENTAL
Intervention: Completing questionnaires and discussing PAID scores
Number of subjects: 19
Study 36104943 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobiliary ablation combined with immune nutrition (IN)
Number of subjects: 59
Study 36104943 — intervention group
Group type: COMPARATOR
Intervention: Control group (PTBD and standard early enteral nutrition)
Number of subjects: 59
Study 34022376 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol-guided individualized nutritional support
Number of subjects: 506
Study 34022376 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital food
Number of subjects: 506
Study 32248795 — intervention group
Group type: EXPERIMENTAL
Intervention: CORE (Cultivating Our Resilience), a 6-week training program to improve resilience
Number of subjects: 324
Study 32248795 — intervention group
Group type: COMPARATOR
Intervention: HLP (Healthy Lifestyle Program), a 6-week training to promote a healthy lifestyle
Number of subjects: 324
Study 32248795 — intervention group
Group type: COMPARATOR
Intervention: WL (Waiting List), waiting list control condition
Number of subjects: 324
Study 32801009 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher genetic allele score
Number of subjects: 117427
Study 32801009 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest vs lowest genetic allele score
Number of subjects: 117427
Study 32801009 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher unweighted allele scores
Number of subjects: 117427
Study 32801009 — intervention group
Group type: EXPERIMENTAL
Intervention: Internally weighted higher allele scores
Number of subjects: 117427
Study 32801009 — intervention group
Group type: EXPERIMENTAL
Intervention: Externally weighted higher allele scores
Number of subjects: 117427
Study 32801009 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in triglycerides by 1 mmol/L (89 mg/dL)
Number of subjects: 117427
Study 36422767 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual follow-up using asynchronous telemedicine system
Number of subjects: 28
Study 36422767 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face follow-up
Number of subjects: 28
Study 33651740 — intervention group
Group type: EXPERIMENTAL
Intervention: Intimate Partner Violence (IPV) screening using the Woman Abuse Screening Tool (WAST)
Number of subjects: 187
Study 33651740 — intervention group
Group type: EXPERIMENTAL
Intervention: Female Sexual Function Index (FSFI-6) total score
Number of subjects: 187
Study 33651740 — intervention group
Group type: EXPERIMENTAL
Intervention: FSFI-6 domain scores (desire, arousal, lubrication, orgasm, satisfaction, pain)
Number of subjects: 187
Study 32459348 — intervention group
Group type: EXPERIMENTAL
Intervention: e-coach-guided, web-based self-help intervention based on cognitive behavioral therapy
Number of subjects: 295
Study 32459348 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 295
Study 34726293 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethosuximide 500 mg t.i.d along with mebeverine 135 mg t.i.d
Number of subjects: 50
Study 34726293 — intervention group
Group type: COMPARATOR
Intervention: Mebeverine 135 mg t.i.d
Number of subjects: 50
Study 33041091 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3 PUFA therapy (2 g daily for 3 months)
Number of subjects: 60
Study 33041091 — intervention group
Group type: COMPARATOR
Intervention: Usual therapy
Number of subjects: 60
Study 35115003 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD) for 12 weeks
Number of subjects: 60
Study 35115003 — intervention group
Group type: COMPARATOR
Intervention: Routine diet for diabetes (Control) for 12 weeks
Number of subjects: 60
Study 35115003 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 60
Study 35115003 — intervention group
Group type: COMPARATOR
Intervention: Routine diet for diabetes (Control)
Number of subjects: 60
Study 34352497 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment-based parenting intervention (Connect)
Number of subjects: 140
Study 34352497 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (control)
Number of subjects: 140
Study 36444835 — intervention group
Group type: EXPERIMENTAL
Intervention: Defaults group
Number of subjects: 65
Study 36444835 — intervention group
Group type: EXPERIMENTAL
Intervention: Online group
Number of subjects: 65
Study 36444835 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study 33646181 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-quantitative risk assessment method
Number of subjects: 10
Study 32791681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonifying Kidney and Invigorating Brain acupuncture plus standardized physical rehabilitation treatment
Number of subjects: 72
Study 32791681 — intervention group
Group type: COMPARATOR
Intervention: Standardized physical rehabilitation treatment
Number of subjects: 72
Study 32249509 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-based group exercise program
Number of subjects: 50
Study 32249509 — intervention group
Group type: COMPARATOR
Intervention: Home-based individual exercise program
Number of subjects: 50
Study 32305012 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Functional Training (CFT)
Number of subjects: 20
Study 32305012 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 20
Study 35766604 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07) for 90 days after surgery
Number of subjects: 101
Study 35766604 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation for 90 days after surgery
Number of subjects: 101
Study 32628678 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest Lee Bounds (RFLB)
Number of subjects: 0
Study 32628678 — intervention group
Group type: COMPARATOR
Intervention: Assuming MCAR or MAR
Number of subjects: 0
Study 32628678 — intervention group
Group type: EXPERIMENTAL
Intervention: Missing outcome data considered as MNAR
Number of subjects: 0
Study 34355784 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive styloid process elongation
Number of subjects: 2010
Study 34355784 — intervention group
Group type: EXPERIMENTAL
Intervention: Type I styloid process elongation
Number of subjects: 2010
Study 34355784 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II styloid process elongation
Number of subjects: 2010
Study 34355784 — intervention group
Group type: EXPERIMENTAL
Intervention: Type III styloid process elongation
Number of subjects: 2010
Study 34355784 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal styloid process
Number of subjects: 2010
Study 34355784 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal styloid process in age group 18-24 years
Number of subjects: 2010
Study 34355784 — intervention group
Group type: EXPERIMENTAL
Intervention: Type I pattern prevalence in age group 30-50 years
Number of subjects: 2010
Study 32813051 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID Impact Survey administered during the pandemic
Number of subjects: 131
Study 32813051 — intervention group
Group type: EXPERIMENTAL
Intervention: HADS-depression scores at follow-up
Number of subjects: 131
Study 32813051 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived impact of the pandemic on psychological well-being
Number of subjects: 131
Study 32813051 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 131
Study 32803127 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral design intervention package (health worker planning calendar, client counseling job aid, client appointment cards)
Number of subjects: 0
Study 32803127 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study 34126291 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Cort:CRPmorn ratio levels at T1
Number of subjects: 122
Study 34126291 — intervention group
Group type: COMPARATOR
Intervention: Lower Cort:CRPmorn ratio levels at T1
Number of subjects: 122
Study 32152929 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional load during enumeration of canonical patterns
Number of subjects: 0
Study 32152929 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional load during enumeration of randomized arrangements
Number of subjects: 0
Study 32152929 — intervention group
Group type: COMPARATOR
Intervention: Centrally located canonical patterns
Number of subjects: 0
Study 36476318 — intervention group
Group type: EXPERIMENTAL
Intervention: HCT Symptoms and Steps intervention
Number of subjects: 40
Study 36476318 — intervention group
Group type: COMPARATOR
Intervention: Education control
Number of subjects: 40
Study 33454813 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional cryoablation
Number of subjects: 23
Study 32521620 — intervention group
Group type: EXPERIMENTAL
Intervention: Purchasing food in modern retailers
Number of subjects: 1429
Study 35794564 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention (8 sessions over 6 months)
Number of subjects: 69
Study 35794564 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 69
Study 34544245 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear sealants
Number of subjects: 6986
Study 34544245 — intervention group
Group type: EXPERIMENTAL
Intervention: Opaque sealants
Number of subjects: 6986
Study 34544245 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissures
Number of subjects: 6986
Study 34544245 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealants on early carious lesions (ICDAS II 1‐3)
Number of subjects: 6986
Study 32729141 — intervention group
Group type: EXPERIMENTAL
Intervention: Gyrus PKS™
Number of subjects: 64
Study 32729141 — intervention group
Group type: COMPARATOR
Intervention: LigaSure™
Number of subjects: 64
Study 34080498 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release (IR) paracetamol
Number of subjects: 9
Study 34080498 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-release (MR) paracetamol
Number of subjects: 9
Study 34080498 — intervention group
Group type: COMPARATOR
Intervention: Both IR and MR paracetamol
Number of subjects: 9
Study 35482532 — intervention group
Group type: EXPERIMENTAL
Intervention: Avacopan 30 mg twice daily for 52 weeks
Number of subjects: 21
Study 35482532 — intervention group
Group type: COMPARATOR
Intervention: Tapered prednisone over 20 weeks plus avacopan-matching placebo for 52 weeks
Number of subjects: 21
Study 33165685 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity simulation (HFS)
Number of subjects: 0
Study 33165685 — intervention group
Group type: COMPARATOR
Intervention: Video-based learning (VBL)
Number of subjects: 0
Study 35088397 — intervention group
Group type: EXPERIMENTAL
Intervention: HOT (35°C, 20.9% FiO2)
Number of subjects: 10
Study 35088397 — intervention group
Group type: EXPERIMENTAL
Intervention: HH (35°C, 14.5% FiO2)
Number of subjects: 10
Study 35088397 — intervention group
Group type: COMPARATOR
Intervention: HYP (20°C, 14.5% FiO2)
Number of subjects: 10
Study 35088397 — intervention group
Group type: COMPARATOR
Intervention: CON (20°C, 20.9% FiO2)
Number of subjects: 10
Study 32203984 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacologic or strategy-driven glucose-lowering interventions
Number of subjects: 36
Study 32203984 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study 33657443 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegbelfermin (PGBF) 10, 20, or 40 mg subcutaneous injections once weekly for 48 weeks
Number of subjects: 0
Study 33657443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36087921 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual simulation-based training program for etonogestrel subdermal contraceptive implant insertion and removal
Number of subjects: 3162
Study 32056721 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose indacaterol acetate/mometasone furoate 150/80 μg once daily
Number of subjects: 802
Study 32056721 — intervention group
Group type: COMPARATOR
Intervention: Mometasone furoate 200 μg once daily
Number of subjects: 802
Study 34600129 — intervention group
Group type: EXPERIMENTAL
Intervention: Locoregional therapy plus adoptive transfer of allogeneic γδ T cells (HCC, Group B; ICC, Group D)
Number of subjects: 59
Study 34600129 — intervention group
Group type: COMPARATOR
Intervention: Locoregional therapy (HCC, Group A; ICC, Group C)
Number of subjects: 59
Study 34600129 — intervention group
Group type: EXPERIMENTAL
Intervention: Locoregional therapy plus adoptive transfer of allogeneic γδ T cells (HCC, Group B)
Number of subjects: 59
Study 34600129 — intervention group
Group type: COMPARATOR
Intervention: Locoregional therapy (HCC, Group A)
Number of subjects: 59
Study 34600129 — intervention group
Group type: EXPERIMENTAL
Intervention: Locoregional therapy plus adoptive transfer of allogeneic γδ T cells (ICC, Group D)
Number of subjects: 59
Study 34600129 — intervention group
Group type: COMPARATOR
Intervention: Locoregional therapy (ICC, Group C)
Number of subjects: 59
Study 35662994 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone
Number of subjects: 70
Study 32945567 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy and therapeutic alliance feedback
Number of subjects: 0
Study 36256926 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE, 0.625 mg/d)
Number of subjects: 9332
Study 36256926 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE + medroxyprogesterone acetate (MPA; 2.5 mg/d)
Number of subjects: 9332
Study 36256926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9332
Study 34429137 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced forced-diuresis using RenalGuard system (RG)
Number of subjects: 220
Study 34429137 — intervention group
Group type: COMPARATOR
Intervention: Control group (current practice)
Number of subjects: 220
Study 33079971 — intervention group
Group type: EXPERIMENTAL
Intervention: Model 1 (FLI plus GLUCOSE plus SEX plus AGE)
Number of subjects: 2970